- Home
- ACFN vs IGC Comparison
ACFN vs IGC Comparison
Compare ACFN & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACFN
- IGC
- Stock Information
- Founded
- ACFN 1986
- IGC 2005
- Country
- ACFN United States
- IGC United States
- Employees
- ACFN N/A
- IGC N/A
- Industry
- ACFN Military/Government/Technical
- IGC Biotechnology: Pharmaceutical Preparations
- Sector
- ACFN Consumer Discretionary
- IGC Health Care
- Exchange
- ACFN Nasdaq
- IGC Nasdaq
- Market Cap
- ACFN 35.2M
- IGC 33.8M
- IPO Year
- ACFN N/A
- IGC N/A
- Fundamental
- Price
- ACFN $13.50
- IGC $0.34
- Analyst Decision
- ACFN
- IGC Strong Buy
- Analyst Count
- ACFN 0
- IGC 2
- Target Price
- ACFN N/A
- IGC $4.00
- AVG Volume (30 Days)
- ACFN 29.5K
- IGC 933.0K
- Earning Date
- ACFN 11-06-2025
- IGC 11-17-2025
- Dividend Yield
- ACFN N/A
- IGC N/A
- EPS Growth
- ACFN 473.47
- IGC N/A
- EPS
- ACFN 2.64
- IGC N/A
- Revenue
- ACFN $12,630,000.00
- IGC $1,106,000.00
- Revenue This Year
- ACFN N/A
- IGC $3.54
- Revenue Next Year
- ACFN N/A
- IGC $15.12
- P/E Ratio
- ACFN $5.36
- IGC N/A
- Revenue Growth
- ACFN 30.11
- IGC N/A
- 52 Week Low
- ACFN $12.42
- IGC $0.25
- 52 Week High
- ACFN $33.00
- IGC $0.50
- Technical
- Relative Strength Index (RSI)
- ACFN 24.76
- IGC 33.05
- Support Level
- ACFN $13.30
- IGC $0.35
- Resistance Level
- ACFN $17.13
- IGC $0.37
- Average True Range (ATR)
- ACFN 1.77
- IGC 0.03
- MACD
- ACFN -0.60
- IGC -0.01
- Stochastic Oscillator
- ACFN 9.86
- IGC 8.59
About ACFN Acorn Energy Inc.
Acorn Energy Inc is a holding company that focuses on technology-driven solutions for energy infrastructure asset management. It operates through two segments namely, the PG segment and the CP segment. PG segment provides wireless remote monitoring and control systems and services for critical assets as well as Internet of Things applications which account for the majority of the revenue. CP segment is engaged in providing remote monitoring of cathodic protection systems on gas pipelines for gas utilities and pipeline companies.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.